TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05781932

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dermal barb suture combined with medical glue
Description: In the experimental group, after tension reduction and suture were completed, the wound and surrounding skin were wiped clean with normal saline and clean gauze, and the blood accumulated in the wound was squeezed out. Histoacryl medical tissue glue (specification:0.5 ml/piece, main components: n-butyl 2-cyanoacrylate (embutate), pigment (1-hydroxy-4\[(toluene)amino\]-9,10-anthraquinone), and stabilizers (p-diphenol, sulfur dioxide, phosphoric acid)) were evenly spread on the surgical incision and kept in the butt state for 4 to 6 seconds. After it got solidify and dry, a sterile gauze covered the surgical incision. There was no need to disinfect and change the dressings after the operation. Patients can shower normally on the day after the operation by just avoiding rubbing the incision covered with glue. Patients can move normally 1-2 days after the operation, and the glue film falls off on its own within 5-10 days.
Study: NCT05551884

Intervention type: PROCEDURE
Intervention: Metabolites and HVPG
Description: HVPG measurement are performed by well-trained interventional radiologists in accordance with standard operating procedures.~All enrolled patients were analyzed for potential differential metabolites using metabolomics.
Study: NCT05582226

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction
Description: Orthopedic surgical operation in which a ruptured anterior cruciate ligament is repaired and reattached to the muscle connection points with a graft, a fashioned ligament that is meant to serve as a replacement for the ruptured muscle tissue.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: ACL reconstruction
Description: Orthopedic surgical operation in which a ruptured anterior cruciate ligament is repaired and reattached to the muscle connection points with a graft, a fashioned ligament that is meant to serve as a replacement for the ruptured muscle tissue.
Study: NCT05407857

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: multi-modal non-pharmacological intervention
Description: multi-modal non-pharmacological intervention including the management with nutrition, exercise and cognitive programs

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: multi-modal non-pharmacological intervention
Description: multi-modal non-pharmacological intervention including the management with nutrition, exercise and cognitive programs

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: multi-modal non-pharmacological intervention
Description: multi-modal non-pharmacological intervention including the management with nutrition, exercise and cognitive programs
Study: NCT05392803

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active then Sham Treatment
Description: Application of 30 days of nonthermal, pulsed shortwave (radiofrequency) therapy; then sham treatment after a 7-day washout period

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham then Active Treatment
Description: Application of 30 days of sham treatment; then 30 days of nonthermal, pulsed shortwave (radiofrequency) therapy after a 7-day washout period
Study: NCT04894890

Intervention type: DRUG
Intervention: secukinumab
Description: There is no treatment allocation. Patients administered secukinumab by prescription that have started before inclusion of the patient into the study will be enrolled.
Study: NCT06485388

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Venous blood samples will be taken from the patients included in the study and incubated with propofol (dose: 100, 250, 500 and 1000µM) after appropriate procedures in the laboratory environment. . After incubation, all resuspensions will be subjected to flow cytometric analysis to evaluate erythrocyte NO synthase activity and erythrocyte-mediated NO release.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thiopental
Description: Venous blood samples will be taken from the patients included in the study and incubated with thiopental (dose: 100, 250, 500 and 1000µM) after appropriate procedures in the laboratory environment. . After incubation, all resuspensions will be subjected to flow cytometric analysis to evaluate erythrocyte NO synthase activity and erythrocyte-mediated NO release.
Study: NCT06006403

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD123 targeted CAR-NK cells
Description: Administration method: intravenous infusion； Subjects will receive conditioning therapy by Fludarabine and Cyclophosphamide before cell infusion.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD123 targeted CAR-NK cells
Description: Administration method: intravenous infusion； Subjects will receive conditioning therapy by Fludarabine and Cyclophosphamide before cell infusion.
Study: NCT05582226

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell implantation
Description: Stem cells are to be extracted from tissue at the stump of the ACL attachment point and inserted on the graft in the hopes of improving healing response
Study: NCT05701527

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EBC-129
Description: EBC-129 will be administered on Day 1 of each 21-Day cycle (Parts A, B, and C), and Day 1 of each 21- or 28-Day cycle (Part D) via a 30-120-minute intravenous (IV) fusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EBC-129
Description: EBC-129 will be administered on Day 1 of each 21-Day cycle (Parts A, B, and C), and Day 1 of each 21- or 28-Day cycle (Part D) via a 30-120-minute intravenous (IV) fusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EBC-129
Description: EBC-129 will be administered on Day 1 of each 21-Day cycle (Parts A, B, and C), and Day 1 of each 21- or 28-Day cycle (Part D) via a 30-120-minute intravenous (IV) fusion.
Study: NCT05907070

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandala group
Description: Mandala group will participate in 2 sessions of individual mandala drawing art activity with the theme of 'Emotions' accompanied by classical or instrumental music. In each session, a mandala will be created.
Study: NCT05549180

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIKTARVY 50Mg-200Mg-25Mg Tablet and Dovato placebo
Description: The patients randomized to experimental arm will be randomized to Biktarvy + Dovato placebo
Study: NCT05907070

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Value clarification group
Description: Value clarification groups will participate in the value clarification activity by writing 2 sessions individually with the theme of 'Emotions' accompanied by classical or instrumental music.
Study: NCT05549180

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dovato 50Mg-300Mg Tablet + Biktarvy placebo
Description: The patients randomized to comparador arm will be randomized to Dovato + Biktarvy placebo
Study: NCT06582173

Intervention type: OTHER
Intervention: Face-to-face interviews assisted by a biographical grid
Description: Face-to-face interviews assisted by a biographical grid.~Healthcare event of the adolescent :~* medical specialist appointment~* general practitioner appointment~* emergency services use~* hospital admission~* diagnostic test~* medication use~* non-pharmacological treatment~* nursing or physical therapy~* alternative care~Biographical of the adolescent :~* Education event~  * Class/level~ * School~ * Attendance~ * Special arrangements~ * Grades~ * Off school education~* Family event~  * Separation/union~ * Birth/death~ * Leave/Arrival~ * Location/Moving~ * Disease/accident~* Peer events~  * Friendships~ * Love interests~ * Bullying~* Leisure \& interests events~  * Activity~ * Frequency

Intervention type: OTHER
Intervention: Face-to-face interviews assisted by a biographical grid
Description: Face-to-face interviews assisted by a biographical grid.~Healthcare event of the adolescent :~* medical specialist appointment~* general practitioner appointment~* emergency services use~* hospital admission~* diagnostic test~* medication use~* non-pharmacological treatment~* nursing or physical therapy~* alternative care~Biographical of the adolescent :~* Education event~  * Class/level~ * School~ * Attendance~ * Special arrangements~ * Grades~ * Off school education~* Family event~  * Separation/union~ * Birth/death~ * Leave/Arrival~ * Location/Moving~ * Disease/accident~* Peer events~  * Friendships~ * Love interests~ * Bullying~* Leisure \& interests events~  * Activity~ * Frequency
Study: NCT06581718

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Eye Gaze Control
Description: Eye Gaze Control - UGI and LGI endoscopy
Study: NCT06332014

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prolia
Description: Partcipants will receive subcutaneous (SC) injections of Prolia Q6M.
Study: NCT06233422

Intervention type: OTHER
Intervention: No intervention involved
Description: No intervention involved

Intervention type: OTHER
Intervention: No intervention involved
Description: No intervention involved
Study: NCT04500665

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine
Description: Colchicine

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05701527

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EBC-129
Description: EBC-129 will be administered on Day 1 of each 21-Day cycle (Parts A, B, and C), and Day 1 of each 21- or 28-Day cycle (Part D) via a 30-120-minute intravenous (IV) fusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EBC-129
Description: EBC-129 will be administered on Day 1 of each 21-Day cycle (Parts A, B, and C), and Day 1 of each 21- or 28-Day cycle (Part D) via a 30-120-minute intravenous (IV) fusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered at the dose of 200 mg IV every 21 days.
Study: NCT05494034

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Reveal LINQTM
Description: implantable cardiac monitoring device (Reveal LINQTM)
Study: NCT00808197

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ocular blood flow measurement
Description: Ocular blood flow will be determined by non-invasive methods, including laser Doppler flowmetry and laser interferometry
Study: NCT04008160

Intervention type: DEVICE
Intervention: ProTex
Description: Non invasive measurement of pressure, temperature, humidity, perfusion, and oxygenation

Intervention type: DEVICE
Intervention: ProTex
Description: Non invasive measurement of pressure, temperature, humidity, perfusion, and oxygenation
Study: NCT04923009

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ICE visualization and map construction
Description: Radio-frequency ablation of atrial fibrillation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ICE visualization and map construction
Description: Radio-frequency ablation of atrial fibrillation
Study: NCT05771974

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Compression therapy using surgical gloves
Description: Intervention group wear two-layer of normal-sized surgical gloves on both hands during chemotherapy infusion
Study: NCT05199389

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multiwave Locked System® (M6 laser, ASA srl, Arcugnano (VI), Italy)
Description: MLS® Laser M6 is a PBM device that allows the patients to be treated in various positions, either sitting, lying down or at a distance, without risk of contamination. Treatment times are carefully calibrated to deliver the best possible energy dose to the tissue being treated.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multiwave Locked System® (M6 laser, ASA srl, Arcugnano (VI), Italy)
Description: MLS® Laser M6 is a PBM device that allows the patients to be treated in various positions, either sitting, lying down or at a distance, without risk of contamination. Treatment times are carefully calibrated to deliver the best possible energy dose to the tissue being treated.
Study: NCT04936048

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Music Therapy
Description: Music therapy will use rhythmic cues, music instruments (piano, drums, djembe, xylophone, harmonica), songs, and stories accompanied by songs or musical instruments to target common goals.
Study: NCT05500911

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sinus lift
Description: when residual bone height is \>4 mm sinus lift through crestal approach procedure will be performed and after sinus flor elevation, OSSIX® Bone will be placed in the sinus cavity.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sinus lift
Description: when residual bone height is \>4 mm sinus lift through crestal approach procedure will be performed and after sinus flor elevation, OSSIX® Bone will be placed in the sinus cavity.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: implant placement
Description: Implant will be placed in edentulous area

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: implant placement
Description: Implant will be placed in edentulous area
Study: NCT04983849

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metronidazole hydrogel
Description: scaling and root planning in adjunct to the use of metronidazole in the periodontal pocket
Study: NCT06080386

Intervention type: DIAGNOSTIC_TEST
Intervention: UDFF
Description: quantification of liver fat: UDFF (lipid fraction derived from ultrasound) from one of the probes of an ultrasound system
Study: NCT04983849

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: scaling and root planning
Description: scaling and root planning
Study: NCT04866147

Intervention type: PROCEDURE
Intervention: Cardiothoracic surgery
Description: Cardiac \& large intrathoracic vessels, respiratory, thoracic, mediastinal \& diaphragmatic procedures

Intervention type: PROCEDURE
Intervention: Breast surgery
Description: Breast resections \& mastectomies

Intervention type: PROCEDURE
Intervention: Gastrointestinal surgery
Description: Digestive \& spleen

Intervention type: PROCEDURE
Intervention: Genitourinary surgery
Description: Urinary tract, genital \& retroperitoneal tissue

Intervention type: PROCEDURE
Intervention: Orthopaedic surgery
Description: Back \& neck, shoulder \& upper arm, hip \& thigh, knees \& lower leg
Study: NCT02546102

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ICT-107
Description: Autologous dendritic cells pulsed with peptides associated with tumor antigens

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Control, autologous monocytes-enriched PBMC.
Study: NCT06005844

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Cerebellar Cognitive-Affective Syndrome Scale
Description: The CCASS will be administered by a neuropsychologist starting with version 1A. An alternative version (1B, 1C or 1D) will also be administered. An interval of approximately 30 minutes should be observed between the two administrations. In order to assess the inter-rater reliability of the scale, a second neuropsychologist will be present in the room and will independently evaluate (i.e., blind to his/her colleague's rating) patient's responses. The choice of alternative version (i.e., 1B, 1C, or 1D) will be randomized.
Study: NCT06499129

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sensory ball, progressive relaxation exercise, training
Description: The effect of sensory ball use on fatigue, peripheral neuropathy and anxiety will be examined
Study: NCT04698200

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold exposure
Description: Whole body resting cold (+10 degrees centigrade) and heat (+40 degrees centigrade) for 60 minutes.
Study: NCT04936048

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Music Therapy
Description: Music therapy will use rhythmic cues, music instruments (piano, drums, djembe, xylophone, harmonica), songs, and stories accompanied by songs or musical instruments to target common goals.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Play therapy
Description: Play therapy is designed as a play-based active comparison condition to control for factors such as support, therapist attention, positive expectancies, and emotional engagement. It will use verbal interaction, toys (Lego, finger puppets, Play Doh, puzzles), and the same stories as in MT, but without a musical component, to target common goals.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Play therapy
Description: Play therapy is designed as a play-based active comparison condition to control for factors such as support, therapist attention, positive expectancies, and emotional engagement. It will use verbal interaction, toys (Lego, finger puppets, Play Doh, puzzles), and the same stories as in MT, but without a musical component, to target common goals.
Study: NCT05746832

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic stenting Retrograde Cholangiopancreatography (ERCP)
Description: Assessment of the differences in stone size and the largest CBD diameter before and after stenting in one or two sessions. Stone clearance and complications were also determined with the ERCP, and factors associated with complete clearance were evaluated in patients with difficult CBD stones (a large \[≥ 20 mm\] or multiple \[≥ 3 sized ≥ 15 mm\] CBD stones). And also compared the outcomes with conventional procedure of open surgery.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic stenting Retrograde Cholangiopancreatography (ERCP)
Description: Assessment of the differences in stone size and the largest CBD diameter before and after stenting in one or two sessions. Stone clearance and complications were also determined with the ERCP, and factors associated with complete clearance were evaluated in patients with difficult CBD stones (a large \[≥ 20 mm\] or multiple \[≥ 3 sized ≥ 15 mm\] CBD stones). And also compared the outcomes with conventional procedure of open surgery.
Study: NCT06182839

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Canagliflozin 300Mg Tab
Description: Patients will get 1 pill of Canagliflozin 300 mg daily for one year.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will get 1 pill of placebo daily for one year.
Study: NCT05476965

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: induction therapy; surgery; radiotherapy
Description: Radiotherapy: de-escalation radiotherapy or standard radiotherapy

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: induction therapy; surgery; radiotherapy
Description: Radiotherapy: de-escalation radiotherapy or standard radiotherapy
Study: NCT04819997

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Intervention
Description: Participate in videoconference session
Study: NCT05856019

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: J Stroke Myofascial Release
Description: Group A will receive J stroke myofascial release on planter fascia (with hot pack for 10-15 minutes on calf) 3 sessions per week for 4 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ischemic Release on Gastrocnemius through Dry Cupping
Description: Group B will ischemic release on gastrocnemius (with hot pack for 10-15 minutes on calf) 3 sessions per week for 4 weeks.
Study: NCT06293313

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mindfulness training
Description: Before starting the study, an appointment will be made to meet with the students participating in the mindfulness group with randomization on the specified day and time. The students and the researcher will meet in a quiet, calm room of the school. Students will be informed about the practice of mindfulness and their written and verbal consents will be obtained before participating in the study. Then, a pre-test will be applied to the students who agree to participate in the study.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Will not be given any application
Description: Before starting the research, the students in the control group determined by the randomization method will be informed about the research. Written and verbal consent will be obtained from the students that the students agree to participate in the research. Afterwards, students will meet in a quiet and calm room of the school on the specified day and time. Before starting the research, students will be given a pre-test. A mid-term test will be performed 8 weeks after the pre-test.
Study: NCT04764318

Intervention type: BEHAVIORAL
Intervention: Remote patient monitoring for hypertension
Description: The intervention involves making available remote physiologic monitoring services for hypertension patients allowable under Medicare for blood pressure (and weight if desired) when ordered by a patient's clinician.

Intervention type: BEHAVIORAL
Intervention: Remote patient monitoring with care management
Description: The intervention involves making available remote physiologic monitoring services for hypertension patients allowable under Medicare for blood pressure (and weight if desired) when ordered by a patient's clinician and providing care management services to support the enrollment and active use of this service.
Study: NCT05998382

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online group-based parent-mediated intervention program
Description: The program is an online group-based parent-mediated intervention program implemented in 2 sessions of 2 hours once a week for 6 weeks. In the first part of the weekly sessions, the topic of that week is explained to the parents. In the second part, videos recorded by the parents are watched and feedback is given to the parents. At the end of the session, written materials about that week's practices and homework are sent to the parents
Study: NCT05176834

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: B-Cure laser pro
Description: The B-Cure laser pro is a portal, non-invasive, photobiomodulation device, that emits light in the near infrared (808nm) over an area of 1X4.5 cm2 with power output of 250mW, and energy dose of 1J/cm2.
Study: NCT05041972

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARX788
Description: ARX788 will be administered by intravenous (IV) infusion every 3 weeks (Q3W).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARX788
Description: ARX788 will be administered by intravenous (IV) infusion every 3 weeks (Q3W).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARX788
Description: ARX788 will be administered by intravenous (IV) infusion every 3 weeks (Q3W).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARX788
Description: ARX788 will be administered by intravenous (IV) infusion every 3 weeks (Q3W).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARX788
Description: ARX788 will be administered by intravenous (IV) infusion every 3 weeks (Q3W).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARX788
Description: ARX788 will be administered by intravenous (IV) infusion every 3 weeks (Q3W).